ReP USP - Resultado da busca

Artigo de periodico
The GA-hecate peptide inhibits the ZIKV replicative cycle in different steps and can inhibit the flavivirus NS2B-NS3 protease after cell infection (2024)
Sanches, Paulo Ricardo da Silva ; Faria, João Caldana Elias de Campos; Bittar, Cintia ; Olivieri, Hugo Alexandre Siqueira Guberovich; Mesquita, Nathalya Cristina de Moraes Roso ; Noske, Gabriela Dias ; Godoy, Andre Schutzer de ; Oliva, Glaucius ; Rahal, Paula ; Cilli, Eduardo Maffud
Source: Protein and Peptide Letters. Unidade: IFSC
Subjects: PROTEÍNAS, PEPTÍDEOS, RESISTÊNCIA MICROBIANA ÀS DROGAS, ZIKA VÍRUS, ESPECTROMETRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANCHES, Paulo Ricardo da Silva et al. The GA-hecate peptide inhibits the ZIKV replicative cycle in different steps and can inhibit the flavivirus NS2B-NS3 protease after cell infection. Protein and Peptide Letters, v. 31, n. 7, p. 532-543, 2024Tradução . . Disponível em: https://doi.org/10.2174/0109298665308871240703090408. Acesso em: 02 nov. 2024.
APA
Sanches, P. R. da S., Faria, J. C. E. de C., Bittar, C., Olivieri, H. A. S. G., Mesquita, N. C. de M. R., Noske, G. D., et al. (2024). The GA-hecate peptide inhibits the ZIKV replicative cycle in different steps and can inhibit the flavivirus NS2B-NS3 protease after cell infection. Protein and Peptide Letters, 31( 7), 532-543. doi:10.2174/0109298665308871240703090408
NLM
Sanches PR da S, Faria JCE de C, Bittar C, Olivieri HASG, Mesquita NC de MR, Noske GD, Godoy AS de, Oliva G, Rahal P, Cilli EM. The GA-hecate peptide inhibits the ZIKV replicative cycle in different steps and can inhibit the flavivirus NS2B-NS3 protease after cell infection [Internet]. Protein and Peptide Letters. 2024 ; 31( 7): 532-543.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2174/0109298665308871240703090408
Vancouver
Sanches PR da S, Faria JCE de C, Bittar C, Olivieri HASG, Mesquita NC de MR, Noske GD, Godoy AS de, Oliva G, Rahal P, Cilli EM. The GA-hecate peptide inhibits the ZIKV replicative cycle in different steps and can inhibit the flavivirus NS2B-NS3 protease after cell infection [Internet]. Protein and Peptide Letters. 2024 ; 31( 7): 532-543.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2174/0109298665308871240703090408
Artigo de periodico
New strategies for novel drugs: antimicrobial peptides containing ferrocene with improved antifungal and antiplasmodial biological activity (2022)
Costa, Natalia Caroline Silva ; Santos Filho, Norival A. ; Piccoli, Julia P. ; Fusco-Almeida, Ana M. ; Santos, Claudia T.; Souza, Juliana Oliveira de; Zanini, Camila Lima; Aguiar, Anna Caroline Campos ; Oliva, Glaucius ; Guido, Rafael Victorio Carvalho ; Cilli, Eduardo M.
Source: Protein and Peptide Letters. Unidade: IFSC
Subjects: AGENTES ANTIMICROBIANOS, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Natalia Caroline Silva et al. New strategies for novel drugs: antimicrobial peptides containing ferrocene with improved antifungal and antiplasmodial biological activity. Protein and Peptide Letters, v. 29, n. 12, p. 1088-1098, 2022Tradução . . Disponível em: https://doi.org/10.2174/0929866529666220929162509. Acesso em: 02 nov. 2024.
APA
Costa, N. C. S., Santos Filho, N. A., Piccoli, J. P., Fusco-Almeida, A. M., Santos, C. T., Souza, J. O. de, et al. (2022). New strategies for novel drugs: antimicrobial peptides containing ferrocene with improved antifungal and antiplasmodial biological activity. Protein and Peptide Letters, 29( 12), 1088-1098. doi:10.2174/0929866529666220929162509
NLM
Costa NCS, Santos Filho NA, Piccoli JP, Fusco-Almeida AM, Santos CT, Souza JO de, Zanini CL, Aguiar ACC, Oliva G, Guido RVC, Cilli EM. New strategies for novel drugs: antimicrobial peptides containing ferrocene with improved antifungal and antiplasmodial biological activity [Internet]. Protein and Peptide Letters. 2022 ; 29( 12): 1088-1098.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2174/0929866529666220929162509
Vancouver
Costa NCS, Santos Filho NA, Piccoli JP, Fusco-Almeida AM, Santos CT, Souza JO de, Zanini CL, Aguiar ACC, Oliva G, Guido RVC, Cilli EM. New strategies for novel drugs: antimicrobial peptides containing ferrocene with improved antifungal and antiplasmodial biological activity [Internet]. Protein and Peptide Letters. 2022 ; 29( 12): 1088-1098.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2174/0929866529666220929162509
Artigo de periodico
New molecular targets and strategies for antimalarial discovery (2019)
Aguiar, Anna Caroline Campos; Sousa, Lorena R. F.; Garcia, Célia Regina da Silva ; Oliva, Glaucius ; Guido, Rafael Victorio Carvalho
Source: Current Medicinal Chemistry. Unidades: IFSC, IB
Subjects: DOENÇAS TROPICAIS ANIMAL, MALÁRIA, PLANEJAMENTO DE FÁRMACOS, ANTIMALÁRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGUIAR, Anna Caroline Campos et al. New molecular targets and strategies for antimalarial discovery. Current Medicinal Chemistry, v. 26, n. 23, p. 4380-4402, 2019Tradução . . Disponível em: https://doi.org/10.2174/0929867324666170830103003. Acesso em: 02 nov. 2024.
APA
Aguiar, A. C. C., Sousa, L. R. F., Garcia, C. R. da S., Oliva, G., & Guido, R. V. C. (2019). New molecular targets and strategies for antimalarial discovery. Current Medicinal Chemistry, 26( 23), 4380-4402. doi:10.2174/0929867324666170830103003
NLM
Aguiar ACC, Sousa LRF, Garcia CR da S, Oliva G, Guido RVC. New molecular targets and strategies for antimalarial discovery [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4380-4402.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2174/0929867324666170830103003
Vancouver
Aguiar ACC, Sousa LRF, Garcia CR da S, Oliva G, Guido RVC. New molecular targets and strategies for antimalarial discovery [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4380-4402.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2174/0929867324666170830103003
Artigo de periodico
Kinetic and crystallographic studies on glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi in complex with iodoacetate (2009)
Guido, Rafael Victorio Carvalho ; Balliano, Tatiane L.; Andricopulo, Adriano Defini ; Oliva, Glaucius
Source: Letters in Drug Design and Discovery. Unidade: IFSC
Subjects: PLANEJAMENTO DE FÁRMACOS, INIBIDORES DE ENZIMAS, TRYPANOSOMA CRUZI (ESTUDO), ENZIMAS, INFECÇÕES POR PROTOZOÁRIOS, CRISTALOGRAFIA DE RAIOS X
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIDO, Rafael Victorio Carvalho et al. Kinetic and crystallographic studies on glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi in complex with iodoacetate. Letters in Drug Design and Discovery, v. 6, n. 3, p. 210-214, 2009Tradução . . Disponível em: https://doi.org/10.2174/157018009787847774. Acesso em: 02 nov. 2024.
APA
Guido, R. V. C., Balliano, T. L., Andricopulo, A. D., & Oliva, G. (2009). Kinetic and crystallographic studies on glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi in complex with iodoacetate. Letters in Drug Design and Discovery, 6( 3), 210-214. doi:10.2174/157018009787847774
NLM
Guido RVC, Balliano TL, Andricopulo AD, Oliva G. Kinetic and crystallographic studies on glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi in complex with iodoacetate [Internet]. Letters in Drug Design and Discovery. 2009 ; 6( 3): 210-214.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2174/157018009787847774
Vancouver
Guido RVC, Balliano TL, Andricopulo AD, Oliva G. Kinetic and crystallographic studies on glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi in complex with iodoacetate [Internet]. Letters in Drug Design and Discovery. 2009 ; 6( 3): 210-214.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2174/157018009787847774
Artigo de periodico
Natural products biological screening and ligand-based virtual screening for the discovery of new antileishmanial agents (2008)
Costa, Fernanda C.; Nicoluci, Ricardo P.; Silva, Márcio; Rocha, Waldireny C.; Vieira, Paulo C.; Oliva, Glaucius ; Thiemann, Otávio Henrique ; Andricopulo, Adriano Defini
Source: Letters in Drug Design and Discovery. Unidade: IFSC
Subjects: FÁRMACOS, PRODUTOS NATURAIS, DOENÇAS INFECCIOSAS, DOENÇAS (TRATAMENTO), LIGANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Fernanda C. et al. Natural products biological screening and ligand-based virtual screening for the discovery of new antileishmanial agents. Letters in Drug Design and Discovery, v. 5, n. 3, p. 158-161, 2008Tradução . . Disponível em: https://doi.org/10.2174/157018008784083956. Acesso em: 02 nov. 2024.
APA
Costa, F. C., Nicoluci, R. P., Silva, M., Rocha, W. C., Vieira, P. C., Oliva, G., et al. (2008). Natural products biological screening and ligand-based virtual screening for the discovery of new antileishmanial agents. Letters in Drug Design and Discovery, 5( 3), 158-161. doi:10.2174/157018008784083956
NLM
Costa FC, Nicoluci RP, Silva M, Rocha WC, Vieira PC, Oliva G, Thiemann OH, Andricopulo AD. Natural products biological screening and ligand-based virtual screening for the discovery of new antileishmanial agents [Internet]. Letters in Drug Design and Discovery. 2008 ; 5( 3): 158-161.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2174/157018008784083956
Vancouver
Costa FC, Nicoluci RP, Silva M, Rocha WC, Vieira PC, Oliva G, Thiemann OH, Andricopulo AD. Natural products biological screening and ligand-based virtual screening for the discovery of new antileishmanial agents [Internet]. Letters in Drug Design and Discovery. 2008 ; 5( 3): 158-161.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2174/157018008784083956
Artigo de periodico
Virtual screening and its integration with modern drug design technologies (2008)
Guido, Rafael Victorio Carvalho ; Oliva, Glaucius ; Andricopulo, Adriano Defini
Source: Current Medicinal Chemistry. Unidade: IFSC
Subjects: FÁRMACOS (DESENVOLVIMENTO), PLANEJAMENTO DE FÁRMACOS, TÉCNICAS DE PROGRAMAÇÃO, TECNOLOGIA FARMACÊUTICA, PROTEÍNAS, LIGANTES, ALGORITMOS GENÉTICOS, ESTRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIDO, Rafael Victorio Carvalho e OLIVA, Glaucius e ANDRICOPULO, Adriano Defini. Virtual screening and its integration with modern drug design technologies. Current Medicinal Chemistry, v. 15, n. Ja 2008, p. 37-46, 2008Tradução . . Disponível em: https://doi.org/10.2174/092986708783330683. Acesso em: 02 nov. 2024.
APA
Guido, R. V. C., Oliva, G., & Andricopulo, A. D. (2008). Virtual screening and its integration with modern drug design technologies. Current Medicinal Chemistry, 15( Ja 2008), 37-46. doi:10.2174/092986708783330683
NLM
Guido RVC, Oliva G, Andricopulo AD. Virtual screening and its integration with modern drug design technologies [Internet]. Current Medicinal Chemistry. 2008 ; 15( Ja 2008): 37-46.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2174/092986708783330683
Vancouver
Guido RVC, Oliva G, Andricopulo AD. Virtual screening and its integration with modern drug design technologies [Internet]. Current Medicinal Chemistry. 2008 ; 15( Ja 2008): 37-46.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2174/092986708783330683

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Grupo de pesquisa